Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	12.4	0.02	0.02	0.18	0.72	3.65
Short-Term Investments	-	-	-	0.89	0.84	0.8
Cash & Short-Term Investments	12.4	0.02	0.02	1.06	1.56	4.45
Cash Growth	1127.62%	-	-98.40%	-31.78%	-65.02%	276.12%
Accounts Receivable	157.28	50.98	73.61	101.6	15.76	16.1
Other Receivables	-	44.97	22.7	-	-	-
Receivables	157.28	95.95	96.31	101.6	15.76	16.49
Inventory	270.9	205.13	137.17	117.05	72.83	121.14
Prepaid Expenses	-	0.83	0.4	0.24	0.11	0.51
Other Current Assets	78.61	7.5	7.17	30.11	5.38	16.85
Total Current Assets	519.19	309.43	241.06	250.06	95.64	159.44
Property, Plant & Equipment	415.51	398.63	293.58	279.13	203.2	169.66
Long-Term Investments	0.49	0.49	0.49	0.49	0.49	0.49
Long-Term Accounts Receivable	42.12	10.83	-	3.97	3.68	2.19
Long-Term Deferred Tax Assets	165.33	108.01	87.33	-	-	-
Other Long-Term Assets	25.02	6.81	5.26	4.79	4.55	3.4
Total Assets	1,168	834.2	631.92	542.65	311.76	338.65
Accounts Payable	770.43	297.94	228.87	237.8	64.59	137.89
Accrued Expenses	-	18.75	19.13	33.78	5.23	8.58
Short-Term Debt	-	399.41	74.63	49.71	10.86	28.5
Current Portion of Long-Term Debt	457.56	7.69	7.69	7.7	-	-
Other Current Liabilities	22.3	134.68	6.62	-	-	-
Total Current Liabilities	1,250	858.47	336.95	328.98	80.68	174.97
Long-Term Debt	270.74	215.22	490.02	622.53	510.43	450.38
Pension & Post-Retirement Benefits	-	8.25	4.8	4.08	2.92	3.8
Long-Term Deferred Tax Liabilities	-	-	-	16.59	14.61	13.4
Other Long-Term Liabilities	13.44	2.5	1.38	32.47	49.41	76.29
Total Liabilities	1,534	1,084	833.15	1,005	658.05	718.83
Common Stock	369.84	369.84	334.84	142.01	142.01	102.01
Additional Paid-In Capital	-	115.91	96.41	-	-	-
Retained Earnings	-	-735.63	-638.81	-604.01	-488.3	-482.2
Comprehensive Income & Other	-736.63	-0.36	6.34	-	-	-
Shareholders' Equity	-366.79	-250.25	-201.22	-462	-346.29	-380.19
Total Liabilities & Equity	1,168	834.2	631.92	542.65	311.76	338.65
Total Debt	728.29	622.32	572.34	679.94	521.29	478.87
Net Cash (Debt)	-715.89	-622.31	-572.32	-678.87	-519.73	-474.42
Net Cash Per Share	-19.40	-17.31	-17.86	-47.80	-40.78	-37.23
Filing Date Shares Outstanding	37.07	36.98	33.48	14.2	14.2	14.2
Total Common Shares Outstanding	37.07	36.98	33.48	14.2	14.2	10.2
Working Capital	-731.09	-549.05	-95.89	-78.92	14.96	-15.53
Book Value Per Share	-9.89	-6.77	-6.01	-32.53	-24.38	-37.27
Tangible Book Value	-366.79	-250.25	-201.22	-462	-346.29	-380.19
Tangible Book Value Per Share	-9.89	-6.77	-6.01	-32.53	-24.38	-37.27
Land	-	-	1.82	1.82	1.82	1.82
Buildings	-	-	78.45	70.43	57.66	42.68
Machinery	-	-	425.07	392.04	304.93	267.34
Construction In Progress	-	-	-	-	3.43	6.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.